2023 Partners




IQVIA is a world leader in using data, technology, advanced analytics, and expertise to help customers drive healthcare forward. Together with the companies we serve, we are enabling a more modern and effective healthcare system and creating breakthrough solutions that transform business and patient outcomes.
Learn More






TopLine Power® is what Simon-Kucher is all about. We help clients grow revenue through optimization of strategy, pricing, marketing, and sales across industries.
We are a thought leader in these topics at the intersection of digitalization and life sciences, positioning our clients thrive in the healthcare industry of the future.
Learn More






ZS is a professional services firm that works side by side with companies to help develop and deliver products that drive customer value and company results. We leverage our deep industry expertise, leading-edge analytics, technology and strategy to create solutions that work in the real world. With more than 35 years of experience and 10,000-plus ZSers in more than 25 offices worldwide, we are passionately committed to helping companies and their customers thrive.
Learn More






BrightInsight provides the leading global regulated digital health platform for biopharma and medtech. Every line of code of our BrightInsight Platform is built under a Quality Management System to support and optimize regulated drugs, devices and software through integrated data and actionable insights to enable customers to drive increased patient adherence and engagement. The BrightInsight™ Platform uses software and services to capture, transmit and analyze data from CE-marked and FDA-regulated medical devices, combination products, apps and Software as a Medical Device, in compliance with global security, privacy and regulatory requirements. Deployed as a managed service, the platform accelerates time to market for biopharma and medtech companies, reduces the cost of implementation and maintenance versus a custom solution, and scales across products and global markets.
Learn More






DTxCC: a boutique consultancy focused solely on Digital Therapeutics and Digital Health commercialization.
Learn More












Curavit is a “Virtual CRO” that designs and executes decentralized – or “virtual” – clinical trials. Curavit leverages emerging technologies in digital health, cloud computing, and data science to recruit, engage, and monitor diverse patient populations from wherever they live, work, or study; eliminating the need for physical infrastructure and travel, while increasing data quality. Curavit brings together the world’s leading researchers, enrolls previously untapped and underserved patient populations, applies machine learning algorithms to health and social engagement information to recruit participants, and leverages leading telehealth, patient data, and medical device technologies. Curavit’s central virtual site supports remote monitoring and is always audit ready.
Learn More












At our core is perseverance, a fierce determination to overcome any obstacle regardless of setbacks, on behalf of patients and their loved ones. We place greater value on what we can achieve together than on what we can do alone because the needs of those we serve always come first. We will not be bound by doing what’s been done before. Instead, we free ourselves from preconceived notions to discover solutions that advance patient care. Our mission is clear: Otsuka-people, creating new products for better health worldwide.
Learn More






Digital Health Today features the leading innovators and the latest innovations. Tune into our podcasts to hear leaders and entrepreneurs from around the world who are developing, implementing and scaling digital solutions for today’s health and wellness challenges. Join our community and learn more about the latest advances, leading research and best practices for growing and scaling digital health solutions.
Learn More
The time has come to meet in-person once again! Step away from the screen for 3 days of industry-defining discussions and catch up with old colleagues and make new connections within the field. Digital therapeutics is a rapidly evolving industry and the DTx East Summit is where you can come to catch the inside scoop on all the exciting new developments in the space.
When you come to DTx East Summit expect to dive into the best agenda in the industry.Our comprehensive program includes a wide range of topics, from Reimbursement, Regulation, Patient Insights, Clinical Trials, Commercialization, Adoption and more! For the first ever time ever in DTx East history we will have two tracks guiding you through Day 1 and Day 2. For wherever your interest lie we got it covered, join us for DTx101, Next Steps in DTx, Commercial Success or Evidence, feel free to switch between them!
Experts from every stakeholder within the digital therapeutics space will be descending onto Boston in September. Join your peers from leading DTx companies, Pharma, Payers, Providers, Government Bodies, Policy Makers and more! DTx East is the perfect place to come seek out your next partners in digital healthcare.
“The digital therapeutics industry as a whole is incredibly collaborative, and the DTx conference series provides the ideal platform for all stakeholders to come together, share ideas, and leave with the ability to have the most impact on patients’ lives”
“It is by far the people that make these DTx events. The DTx series brings some of the best in class, and I look forward to seeing the group four times a year.”
“DTx East 2022 has been a phenomenal experience, looking forward to the DTx Conference Series in 2023”
“I just see digital health, connected devices, digital therapeutics as the next generation of how we improve patient outcomes. And it’s the reason why we come to DTx because it’s the one event where everyone here has that same mission.“
2023 Speaker Faculty












Kal Patel, MD has over 20 years of experience in pharma, medtech and regulated digital health.
He currently serves as CEO and Co-Founder at BrightInsight, the leading global platform for biopharma and medtech regulated digital health solutions. BrightInsight has raised $166M in financing from world-renowned venture capital firms including General Catalyst, Insight Partners, New Leaf Venture Partners, and Eclipse Ventures, and attracted some of the world’s top biopharma and medtech companies as customers including Sanofi, Novo Nordisk, Roche, AstraZeneca, UCB and CSL Behring, among others.
Prior to founding BrightInsight he was Chief Commercial Officer for Doctor on Demand, now one of the nation’s largest video-medicine provider, with backing from Andreessen Horowitz, Venrock, Google Ventures, and Qualcomm.
Kal founded and built Amgen’s Digital Health business unit where he had end-to-end responsibility for developing and commercializing a portfolio of regulated digital products including connected devices, Software as a Medical Device (SaMD), and algorithms.
Prior to his focus on digital health at Amgen, Kal was the Global Marketing Lead for Enbrel, the company’s leading drug with over $6B in sales, where he created and launched major investments in novel clinical trials, innovative drug delivery devices, improved formulations and differentiated patient support programs. Kal started his Amgen career as Head of Corporate Strategy.
Kal also spent several years at Novartis Pharmaceuticals in various sales, marketing and account leadership roles. He began his professional career at the Boston Consulting Group where he worked for a broad portfolio of Healthcare companies across the U.S. and Europe. He transferred to the company’s Budapest office as part of BCG’s prestigious Ambassador program and was promoted early to Principal. Kal has also served as a Senior Advisor in Digital Health to the Boston Consulting Group where he helped C-level executives at pharma and medtech companies develop and execute digital health strategies.


As Managing Director & General Manager for Fitbit Health Solutions at Google, Amy leads the team working with employers, health plans and health systems to design solutions and programs focused on engagement, positive return on investment and health outcomes. Previously, Amy was Chief Operating Officer of Fitbit Health Solutions, and also took on several key positions leading Fitbit’s B2B efforts. Prior to Fitbit, Amy held strategic roles at CNET Networks, including Director of Audience and Content Development for the Community Division and Director of Strategic Partnerships for the Network. Amy has a bachelor’s degree from Merrimack College in Andover, MA and a Professional Certificate in Integrated Marketing Communications from the UC Berkeley Extension program. Amy used to run marathons, but today she gets her steps by chasing her two young boys around. They keep her busy enough to walk the equivalent of one full circle around the earth.


Dr. Andrey Ostrovsky was the former Chief Medical Officer of the US Medicaid program. He is the Managing Partner at Social Innovation Ventures where he invests in and advises companies, non-profits, and artists dedicated to eliminating disparities. He also advises federal and state regulators on how to incorporate human centered design into policy making. He previously operated a series of methadone clinics in Baltimore, Maryland. Prior to working on the front line of the opioid use disorder crisis, he served as the Chief Medical Officer for the Center for Medicaid and CHIP Services, the nation’s largest health insurer, where he advocated to protect the program against several legislative efforts to significantly dismantle the program. He also led efforts to streamline Medicaid and make it more customer-centric. Before leading the Medicaid program, he co-founded the software company, Care at Hand, an evidence-based predictive analytics platform that used insights of non-medical staff to prevent aging people from being hospitalized. Care at Hand was acquired in 2016 by Mindoula Health. Before Care at Hand, Dr. Ostrovsky led teams at the World Health Organization, United States Senate, and San Francisco Health Department toward health system strengthening. Dr. Ostrovsky has served on several boards and committees dedicated to behavioral health, interoperability standards, quality measurement, and home and community based services including the National Academies of Medicine, National Quality Forum, Institute for Healthcare Improvement, and the Commonwealth Fund.










Alyssa Reisner is a Lead Director and Principal at CVS Health Ventures. In
her role, she sources, evaluates, and executes investments in innovative
health care companies. She has built strategic relationships and executed
investments for CVS Health in areas spanning DTx, women’s health,
behavioral health, COVID-19 initiatives, and more.








Vijay Ravindran is the founder and CEO of Floreo, a virtual reality therapeutic for people with autism spectrum disorder, ADHD and anxiety.
Ravindran’s career spans digital commerce and news media. He joined Amazon in 1998 when the company sold books and music. He later served as director of the ordering department at Amazon and led the team that launched Amazon Prime. As Chief Digital Officer for The Washington Post Company, he founded WaPo Labs and oversaw the development of over a dozen products in digital news and launched Washington Post Social Reader and Trove, a personalized news web application.
He is an engineering graduate of the University of Virginia and serves on the Board of The Lenfest Institute for Journalism and Athanase Innovation AB.










Dr. Risa Weisberg has devoted her career to developing and scientifically testing scalable interventions for common behavioral health problems. Her mission is to expand the reach of high-quality, science-based behavioral health treatment. She has over two decades of research, clinical, and leadership experience which she now brings to lead the clinical direction and research strategy of BehaVR at Chief Clinical Officer. Risa has a doctoral degree in Clinical Psychology from the University at Albany. She completed a doctoral internship and postdoctoral fellowship at Brown University. She is a Professor of Psychiatry at the Boston University School of Medicine and an Adjunct Professor of Family Medicine at the Alpert Medical School of Brown University. She is an expert in cognitive-behavioral therapy and acceptance and commitment therapies. As a primary care psychologist, Risa has broad experience in treatment development and implementation for common behavioral health problems including anxiety, depression, chronic pain, substance use disorder, and adaptation to living with other chronic medical difficulties. Her research has been funded by the National Institutes of Health, the Patient Centered Outcomes Research Institute, the Veterans Administration, and numerous foundations. Risa is a member of the Scientific Council of the Anxiety and Depression Association of America and a Fellow and former Board Member of the Association for Behavioral and Cognitive Therapies.




Linda Li joined Cleveland Clinic in 2022 as Partner focusing on Digital Health. She is responsible for the health tech investments and portfolio companies, particularly in artificial intelligence and machine learning-enabled clinical breakthrough technologies.
Prior to joining Cleveland Clinic, Linda was a Co-founding Partner of Vickers Venture Partner and an investment committee member where she oversaw investments in China, Southeast Asia, and the United States.
Linda is active in community volunteerism where she advocates for digital health, women and youth career growth. She serves on the board of CFA Society Shanghai and is an advisor to many incubators to promote startups with women leadership.
Linda graduated from Beijing University and subsequently earned her Master’s Degree from the National University of Singapore. She also holds a dual Bachelor of Arts in the German Language and is a CFA charter holder. She is a Kauffman Fellow (Class of ‘16) and is currently in a PhD program studying digital health and its implementation at Johns Hopkins University.


Anish has 13+ years in Health, and
Digital Therapeutics. Sales & Marketing is his
core strength for driving
adoption of new tech
trends for top line or
bottom-line impact. Executed 23 Bio-Pharma
partnerships &
collaborations; 5 CVC
investments within
HealthTech companies in
the past 6 years. Recently he started his
venture, GSD Health, with
partners that share the
same purpose of “Making
startups Investable &
Successful”








































Kristin Wynholds is Better’s Chief Product Officer. Most recently, she was Principal Product Designer at Carbon Five, a digital product development consultancy. Kristin has led or been involved with more than 30 digital product launches for companies including Stanford Health and Grand Rounds. Kristin has a B.A. degree in psychology from UC Santa Barbara. At Better, Kristin’s passion is ensuring the clinical team’s most ambitious visions become elegant, effective treatments for Type 2 Diabetes and other cardiovascular and metabolic diseases.
































Frank has almost 3 decades of experience in the financial and life-sciences sectors, helping build companies that successfully developed and commercialized multiple products. He has a long standing passion for the intersection of medical science and digital technology and how it can be applied to improve human health. Prior to Better Therapeutics, Frank was President and Chief Financial Officer of Myovant Sciences where he led the company’s efforts to raise approximately $2 billion in capital and its evolution from a private start-up organization to a publicly listed commercial stage company with two marketed products. He also served as Executive Vice President and Chief Financial Officer at Exelixis, Inc. for over a decade, as the company evolved from a discovery to a commercial organization.


















Diane has more than two decades experience in the medtech, consumer care and pharmaceutical sectors with significant experience in P&L management, operations, multichannel distribution, and marketing. Diane spent 17 years in the MedTech sector at Johnson & Johnson, ascending through strategic and commercial roles. While there, she oversaw specialty areas including plastic and reconstructive surgery, biosurgery, interventional cardiology, neurovascular, and peripheral vascular, ultimately holding the title of Worldwide President, Mentor. Diane went on to serve as U.S. President for Galderma, an integrated dermatology company across aesthetics, consumer care and prescription medicines where she led a major transformation for the company and delivered double-digit growth.








Venue and Accommodation
We’re thrilled to announce that the 6th Annual DTx East Summit is coming to the The Westin Boston Seaport District, situated in one of the city’s most vibrant and diverse neighbourhoods.
The Seaport District is a hub of activity, offering our guests plenty of opportunities to explore the local area. We are nestled just a short walk from some of Boston’s finest restaurants and easily accessible with World Trade Center Station just steps away.
Please click here to book your room The Westin Boston Seaport District at a discounted price
Partner With Us
The DTx summits are the premier event series for senior executives from DTx companies, Pharma, Investors, HCPs, Payers and more.
DTx East 2023 is the 17th summit in the DTx series. The industry leaders and most exciting newcomers will be in attendance across an in-person and online event.
The DTx series provides a rare opportunity to showcase your business to a world-class audience. Spaces are limited this year, please contact our commercial manager, Sam (sam@greygreenmedia.com), to discuss your bespoke package.


Register for the Event
For pricing and booking options for DTx East 2023 please click the button to go to the registration page.